Day One Biopharmaceutical... (DAWN)
NASDAQ: DAWN
· Real-Time Price · USD
6.53
0.28 (4.48%)
At close: Aug 15, 2025, 1:22 PM
Day One Biopharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for DAWN stock have an median target of 27, with a low estimate of 25 and a high estimate of 34. The median target predicts an increase of 313.48% from the current stock price of 6.53.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 25 | 28.6 | 27 | 34 |
| Change | 282.85% | 337.98% | 313.48% | 420.67% |
Latest Analyst Insight Report
HC Wainwright & Co. reaffirmed a Buy rating for Da... Unlock content with Pro Subscription
Updated Aug 06, 2025
| Rating | Jan 25 | Feb 25 | Mar 25 | Apr 25 | May 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 4 | 2 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 2 | 1 | 1 | 2 |
Financial Forecast this Year
Revenue This Year
144.7M
from 131.16M
Increased by 10.3%
Revenue Next Year
213.43M
from 144.7M
Increased by 47.5%
EPS This Year
-1.25
from -1.02
Increased by -22.5%
EPS Next Year
-0.78
from -1.25
Increased by 37.6%